基本信息
浏览量:107
职业迁徙
个人简介
Professor Julian Rayner, whose research at the Wellcome Sanger Institute has made significant contributions to our understanding of malaria parasites, took over as Director of the Cambridge Institute of Medical Research (CIMR) on 1 May 2019.
The CIMR is one of the flagship non-clinical research facilities on the Cambridge Biomedical Campus. It brings together clinicians and non-clinical researchers in a mutually productive partnership, using cell biology to understand the cellular basis of disease, and studying genetic disease to reveal crucial mechanisms of cell biology.
Julian’s research helps to identify new malaria drug and vaccine targets by investigating the interactions between Plasmodium parasites – the organism that causes malaria – and human red blood cells. After undergraduate education in New Zealand and a PhD at the MRC Laboratory of Molecular Biology in Cambridge, he began working on malaria cell biology as a postdoctoral fellow at the Centers for Disease Control and Prevention in Atlanta, followed by his first faculty position at the University of Alabama at Birmingham.
Since 2008 he has been a Group Leader at the Wellcome Sanger Institute, during which time he and collaborators have identified an essential protein complex involved in the invasion of red blood cells by malaria parasites. This is now in early stage human vaccine testing. They have also traced the origins of human malaria parasites in African apes, and carried out the first ever genome-scale genetic screenings in Plasmodium parasites, helping to identify new targets for drug development.
At the Sanger Institute, Julian was Director of Graduate Studies from 2012 to 2014 and since 2014 has been Director of Wellcome Genome Campus Connecting Science, a multidisciplinary training and engagement programme which aims to enable everyone to explore genomics and its impact on research, health and society. He is strongly committed to public engagement and will maintain his role with Connecting Science while at CIMR, helping to forge even stronger links between the University of Cambridge and the Wellcome Genome Campus.
The CIMR is one of the flagship non-clinical research facilities on the Cambridge Biomedical Campus. It brings together clinicians and non-clinical researchers in a mutually productive partnership, using cell biology to understand the cellular basis of disease, and studying genetic disease to reveal crucial mechanisms of cell biology.
Julian’s research helps to identify new malaria drug and vaccine targets by investigating the interactions between Plasmodium parasites – the organism that causes malaria – and human red blood cells. After undergraduate education in New Zealand and a PhD at the MRC Laboratory of Molecular Biology in Cambridge, he began working on malaria cell biology as a postdoctoral fellow at the Centers for Disease Control and Prevention in Atlanta, followed by his first faculty position at the University of Alabama at Birmingham.
Since 2008 he has been a Group Leader at the Wellcome Sanger Institute, during which time he and collaborators have identified an essential protein complex involved in the invasion of red blood cells by malaria parasites. This is now in early stage human vaccine testing. They have also traced the origins of human malaria parasites in African apes, and carried out the first ever genome-scale genetic screenings in Plasmodium parasites, helping to identify new targets for drug development.
At the Sanger Institute, Julian was Director of Graduate Studies from 2012 to 2014 and since 2014 has been Director of Wellcome Genome Campus Connecting Science, a multidisciplinary training and engagement programme which aims to enable everyone to explore genomics and its impact on research, health and society. He is strongly committed to public engagement and will maintain his role with Connecting Science while at CIMR, helping to forge even stronger links between the University of Cambridge and the Wellcome Genome Campus.
研究兴趣
论文共 250 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Emma Kals, Morten Kals, Rebecca A. Lees,Viola Introini,Alison Kemp,Eleanor Silvester,Christine R. Collins, Trishant Umrekar,Jurij Kotar,Pietro Cicuta,Julian C. Rayner
biorxiv(2024)
Nature communicationsno. 1 (2023): 5703-17
引用0浏览0引用
0
0
Research Square (Research Square) (2023)
引用0浏览0引用
0
0
Alebachew Messele Kebede, Edwin Sutanto,Hidayat Trimarsanto,Ernest Diez Benavente, Mariana Barnes,Richard D Pearson,Sasha V Siegel,Berhanu Erko,Ashenafi Assefa,Sisay Getachew, Abraham Aseffa,Beyene Petros,
Scientific reportsno. 1 (2023): 20788-20788
Molecular diagnosis & therapyno. 5 (2023): 583-592
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn